EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol

Janina Trauth, Rahel Schuler, Markus Waitz, Harald Ehrhardt, Moritz Fritzenwanker, Susanne Herold

Infection · 2025

DOI: 10.1007/s15010-024-02404-9 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Infection, 2025. Verfasst von Janina Trauth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine V - Internal Medicine, Infectious Diseases & Infection Control, Justus- Liebig-University, member of the German Center for Lun…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cephalosporins, Cross Infection, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Justus-Liebig-Universität Gießen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCephalosporinsCross InfectionGram-Negative Bacterial InfectionsHealthcare-Associated PneumoniaPneumonia, BacterialStenotrophomonas maltophiliaFemaleHumansInfant, NewbornCefiderocolTreatment Outcome

Stichwörter der Autor:innen

Stenotrophomonas maltophiliaCefiderocolMulti drug resistanceNeonatePneumogenic sepsis

Substanzen

Anti-Bacterial AgentsCefiderocolCephalosporins

Autor:innen und Institutionen

  • Department of Medicine V - Internal Medicine, Infectious Diseases & Infection Control, Justus- Liebig-University, member of the German Center for Lung Research (DZL) and German Center for Infection Research (DZIF) and C…
  • Department of General Pediatrics and Neonatology, Justus Liebig University, Giessen, Germany.
  • Division of Neonatology and Pediatric Intensive Care Medicine, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.
  • Institute of Medical Microbiology, Justus Liebig University Giessen, Giessen, Germany.

Förderung

  • Justus-Liebig-Universität Gießen

Zitieren

APA

Trauth, J., Schuler, R., Waitz, M., Ehrhardt, H., Fritzenwanker, M., & Herold, S. (2025). Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol. Infection. https://doi.org/10.1007/s15010-024-02404-9

Vancouver

Trauth J, Schuler R, Waitz M, Ehrhardt H, Fritzenwanker M, Herold S. Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol. Infection. 2025. doi:10.1007/s15010-024-02404-9

BibTeX
@article{Trauth2025,
  author = {Trauth, Janina and Schuler, Rahel and Waitz, Markus and Ehrhardt, Harald and Fritzenwanker, Moritz and Herold, Susanne},
  title = {Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-024-02404-9}
}
Kostenlos starten →